Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Amylase

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44344   clinical trials with a EudraCT protocol, of which   7373   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    Query did not match any clinical trials.
    These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006).
    Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records.
    1  2  Next»
    Study title: Rapport final d’essai Clinique de MAXILASE sirop dans les otites séreuses de l’enfant
    Active substance: alpha-amylase
    Study summary document link (including results): Alpha-Amylase STUDY 248-6-012-1.xls
    View full study record
    Document reference: 47962
    Study title: Comparaison de l'efficacité et de la tolérance du morniflumate suppositoire enfant et de l'alpha amylase sirop dans le traitment des angines de l'enfant. M.Chelly et al; Ann.Pédiatric (Paris), 1996.43 nº5 392-402Comparaison de l'efficacité et de la tolérance du morniflumate suppositoire enfant et de l'alpha amylase sirop dans le traitment des angines de l'enfant. M.Chelly et al; Ann.Pédiatric (Paris), 1996.43 nº5 392-402
    Active substance: DIASTASE
    Study summary document link (including results):
    View full study record
    Document reference: 25927
    Study title: AN 1995094011 19950101. TI Reversal of anorexia in a child with partial ornithine transcarbamylase deficiency by cyproheptadine therapy. AU Lerman-Sagie-T, Mimouni-M. IN Child Development Center, 14 Balfour Street, Tel Aviv, Israel. SO Clinical Pediatrics {CLIN-PEDIATR}, 1995, Vol/Iss/Pg. 34/3 (163-165), ISSN: 0009-9228. YR 1995.AN 1995094011 19950101. TI Reversal of anorexia in a child with partial ornithine transcarbamylase deficiency by cyproheptadine therapy. AU Lerman-Sagie-T, Mimouni-M. IN Child Development Center, 14 Balfour Street, Tel Aviv, Israel. SO Clinical Pediatrics {CLIN-PEDIATR}, 1995, Vol/Iss/Pg. 34/3 (163-165), ISSN: 0009-9228. YR 1995.
    Active substance: CYPROHEPTADINE
    Study summary document link (including results):
    View full study record
    Document reference: 25260
    Study title: Dr. M. Chelly. Essai controle en ouvert evaluant l'efficacitè et la tolèrance du morniflumate suppositoire enfant versus alpha-amylase sirop dans les angines.
    Active substance: MORNIFLUMATE
    Study summary document link (including results):
    View full study record
    Document reference: 32435
    Study title: Dr. M. Chelly.Essai controle en ouvert evaluant l'efficacitè et la tolèrance du morniflumate suppositoire enfant versus alpha-amylase sirop dans les angines.
    Active substance: NIFLUMIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 32638
    Study title: 10.) Oral enzyme therapy in the treat- ment of recurrent respiratory inflamma- tions in patients with indication of immunological in- vestigation before start of treatment
    Active substance: Pancreatin Papain (HERB) Rutosid • 3 H2O Bromelain (HERB) Trypsin Chymotrypsin Amylase Lipase
    Study summary document link (including results):
    View full study record
    Document reference: 40102
    Study title: 11.) Systemic en- zyme therapy in the treatement of supra- condylar fractures of the humerus in Children
    Active substance: Pancreatin Papain (HERB) Rutosid • 3 H2O Bromelain (HERB) Trypsin Chymotrypsin Amylase Lipase
    Study summary document link (including results):
    View full study record
    Document reference: 40103
    Study title: 12.) Influence of Wobenzym treat- ment in children with increased sickness rate
    Active substance: Pancreatin Papain (HERB) Rutosid • 3 H2O Bromelain (HERB) Trypsin Chymotrypsin Amylase Lipase
    Study summary document link (including results):
    View full study record
    Document reference: 40104
    Study title: 14.) Oral Enzyme Therapy of Re- current Respiratory Inflammations in Children
    Active substance: Pancreatin Papain (HERB) Rutosid • 3 H2O Bromelain (HERB) Trypsin Chymotrypsin Amylase Lipase
    Study summary document link (including results):
    View full study record
    Document reference: 40105
    Study title: 16.) Evaluation of effectivness of Wobenzym Therapy in children with recurrent obstructive bronchitis
    Active substance: Pancreatin Papain (HERB) Rutosid • 3 H2O Bromelain (HERB) Trypsin Chymotrypsin Amylase Lipase
    Study summary document link (including results):
    View full study record
    Document reference: 40106
    Study title: 18.) Prophylaxis and treatment chronic hepatitis in children
    Active substance: Pancreatin Papain (HERB) Rutosid • 3 H2O Bromelain (HERB) Trypsin Chymotrypsin Amylase Lipase
    Study summary document link (including results):
    View full study record
    Document reference: 40107
    Study title: 19.) Efficacy of oral enzyme therapy in the complex treat- ment of atopic dermatitis in children
    Active substance: Pancreatin Papain (HERB) Rutosid • 3 H2O Bromelain (HERB) Trypsin Chymotrypsin Amylase Lipase
    Study summary document link (including results):
    View full study record
    Document reference: 40108
    Study title: 20.) Efficacy of oral enzyme therapy in children with atopic dermatitis
    Active substance: Pancreatin Papain (HERB) Rutosid • 3 H2O Bromelain (HERB) Trypsin Chymotrypsin Amylase Lipase
    Study summary document link (including results):
    View full study record
    Document reference: 40109
    Study title: 22.) Enzyme prepa- rations in abdominal surgery
    Active substance: Pancreatin Papain (HERB) Rutosid • 3 H2O Bromelain (HERB) Trypsin Chymotrypsin Amylase Lipase
    Study summary document link (including results):
    View full study record
    Document reference: 40110
    Study title: 23.) Use of Woben- zym for pseudo- tuberculosis and yersiniosis of children
    Active substance: Pancreatin Papain (HERB) Rutosid • 3 H2O Bromelain (HERB) Trypsin Chymotrypsin Amylase Lipase
    Study summary document link (including results):
    View full study record
    Document reference: 40111
    Study title: 8.) An open pilot clinical trial Woben- zym for imporvement of treatment results in resistant and complicated case of pulmonary tuberculo- sis
    Active substance: Pancreatin Papain (HERB) Rutosid • 3 H2O Bromelain (HERB) Trypsin Chymotrypsin Amylase Lipase
    Study summary document link (including results):
    View full study record
    Document reference: 40100
    Study title: 9.) Clinical efficacy of orally applied enzyme medicine Wobenzym in pa- tients with first time diagnosed diabetes mellitus
    Active substance: Pancreatin Papain (HERB) Rutosid • 3 H2O Bromelain (HERB) Trypsin Chymotrypsin Amylase Lipase
    Study summary document link (including results):
    View full study record
    Document reference: 40101
    Study title: Efficacy and Safety of Woben- zym as Antidema- tous Therapy in Dentosurgical Operations
    Active substance: Pancreatin Papain (HERB) Rutosid • 3 H2O Bromelain (HERB) Trypsin Chymotrypsin Amylase Lipase
    Study summary document link (including results):
    View full study record
    Document reference: 40096
    Study title: Efficacy and Safety of Woben- zym as Antidema- tous Therapy in Meniscectomies
    Active substance: Pancreatin Papain (HERB) Rutosid • 3 H2O Bromelain (HERB) Trypsin Chymotrypsin Amylase Lipase
    Study summary document link (including results):
    View full study record
    Document reference: 40097
    Study title: Efficacy and Safety of Woben- zym/Wobenzym N in the post trau- matic treatment after sport injuries and surgery
    Active substance: Pancreatin Papain (HERB) Rutosid • 3 H2O Bromelain (HERB) Trypsin Chymotrypsin Amylase Lipase
    Study summary document link (including results):
    View full study record
    Document reference: 40099
    1  2  Next»
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Wed Jun 18 12:52:52 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA